Nevro Corp (NYSE:NVRO)
| 153.06 BATS BZX Real-Time Price As of 1:15pm ET |  +0.57 / +0.37%Today’s Change | 65.05 Today|||52-Week Range 155.16 | +30.22% Year-to-Date |
Latest NVRO News | Press Releases
| Here's Why You Should Hold on to Nevro (NVRO) Stock Now Oct 14 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 152.49 |
| Today’s open | 153.91 |
| Day’s range | 152.63 - 155.16 |
| Volume | 35,496 |
| Average volume (3 months) | 298,616 |
| Market cap | $5.2B |
Data as of 1:15pm ET, 10/19/2020
Growth & Valuation
| Earnings growth (last year) | -105.58% |
| Earnings growth (this year) | +12.89% |
| Earnings growth (next 5 years) | +13.00% |
| Revenue growth (last year) | +0.77% |
| P/E ratio | NM |
| Price/Sales | 9.28 |
| Price/Book | 22.27 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| IRTCiRhythm Technologies... | -5.97 | -2.53% |
| TNDMTandem Diabetes Care... | +0.33 | +0.28% |
| LIVNLivaNova PLC | -1.56 | -2.76% |
| BEATBioTelemetry Inc | -0.42 | -0.93% |
Data as of 1:15pm ET, 10/19/2020
Financials
| Next reporting date | November 9, 2020 |
| EPS forecast (this quarter) | -$0.58 |
| Annual revenue (last year) | $390.3M |
| Annual profit (last year) | -$103.7M |
| Net profit margin | -26.57% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Redwood City, California |
Forecasts
